S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
Log in

NYSE:GMEDGlobus Medical Earnings Date, Estimates & History

$57.82
+7.16 (+14.13 %)
(As of 08/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$54.00
Now: $57.82
$58.23
50-Day Range
$45.00
MA: $47.72
$50.66
52-Week Range
$33.41
Now: $57.82
$60.15
Volume3.00 million shs
Average Volume1.04 million shs
Market Capitalization$5.64 billion
P/E Ratio39.88
Dividend YieldN/A
Beta0.97

Earnings

Globus Medical (NYSE:GMED) Earnings Information

Globus Medical last issued its earnings data on August 5th, 2020. The medical device company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of ($0.11) by $0.18. Globus Medical has generated $1.68 earnings per share over the last year and currently has a price-to-earnings ratio of 39.9. Globus Medical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 4th, 2020 based off prior year's report dates.

Globus Medical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Globus Medical (NYSE:GMED) Earnings Estimates

2020 EPS Consensus Estimate: $1.87
2021 EPS Consensus Estimate: $1.95
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20205$0.42$0.43$0.43
Q2 20205$0.43$0.48$0.45
Q3 20204$0.43$0.48$0.46
Q4 20205$0.52$0.57$0.54
Q1 20212$0.37$0.50$0.44
Q2 20212$0.42$0.55$0.49
Q3 20212$0.47$0.52$0.50
Q4 20211$0.53$0.53$0.53

Globus Medical (NYSE GMED) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/4/2020
(Estimated)
       
8/5/20206/30/2020($0.11)$0.07$0.35Listen
5/7/20203/31/2020$0.38$0.29$0.33$192.88 million$190.60 millionTranscript
2/20/2020Q4 2019$0.52$0.49$0.54$211.11 million$211.67 millionTranscript
11/6/2019Q3 2019$0.42$0.43$0.48$185.86 million$196.22 millionTranscript
8/1/2019Q2 2019$0.41$0.41$0.44$184.93 million$150.55 millionTranscript
5/2/20193/31/2019$0.41$0.36$0.39$186.59 million$182.90 millionTranscript
2/21/201912/31/2018$0.40$0.43$0.50$195.50 million$195.94 millionListen
11/8/20189/30/2018$0.33$0.39$0.43$167.47 million$169.20 millionListen
8/1/2018Q2 2018$0.35$0.44$0.44$168.03 million$173.40 millionN/A
5/2/2018Q1 2018$0.36$0.41$0.43$167.95 million$174.41 millionTranscript
2/21/2018Q4 2017$0.35$0.38$0.51$175.50 million$176.03 millionTranscript
11/8/2017Q3 2017$0.30$0.30$0.34$150.73 million$151.74 millionN/A
8/2/2017Q2 2017$0.30$0.32$0.35$150.94 million$152.39 millionListen
5/3/2017Q1 2017$0.3050$0.32$0.34$155.81 millionListen
2/27/2017Q416$0.33$0.31$0.37$149.30 million$151.59 millionListen
11/8/2016Q3$0.28$0.29$0.31$139.25 million$135.70 millionListen
7/26/2016Q2$0.29$0.29$0.31$141.78 million$137.49 millionListen
5/3/2016Q1$0.28$0.29$0.29$140.30 million$139.30 millionListen
2/24/2016Q4$0.30$0.32$0.25$141.20 million$142.60 millionListen
11/3/2015Q3$0.25$0.28$0.28$127.46 million$137.00 millionListen
7/30/2015Q215$0.25$0.25$0.25$126.89 million$133.60 millionListen
5/5/2015Q115$0.24$0.26$0.26$122.30 million$131.60 millionListen
2/25/2015Q414$0.25$0.30$0.31$127.77 million$128.80 millionListen
10/30/2014Q314$0.21$0.24$0.24$113.10 million$117.80 millionListen
8/5/2014Q214$0.23$0.23$0.24$119.83 million$113.60 millionListen
4/29/2014Q114$0.22$0.24$0.26$113.59 million$114.20 millionListen
2/26/2014Q4 2013$0.22$0.25$0.28$114.96 million$115.20 millionListen
10/30/2013Q3 2013$0.19$0.22$0.22$106.00 million$107.19 millionListen
8/1/2013Q2 2013$0.20$0.21$0.34$107.46 million$107.00 millionListen
5/2/2013Q1 2013$0.20$0.21$0.21$103.14 million$105.00 millionListen
2/27/2013Q4 2012$0.19$0.22$99.13 million$100.50 millionListen
11/1/2012Q312$0.19$0.18$95.32 million$94.76 millionN/A
8/21/2012Q2 2012$0.25$0.25N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.